🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

448 results for “RAD” Clear

  1. tradipitant

    Vanda Pharmaceuticals Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  2. ALUTARD SQ epitel, injektionsvätska, suspension - 553 Hund, Livostin 0,5 mg/ml ögondroppar, suspension, Desloratadine Sandoz 5 mg filmdragerade tabletter, Nasonex 50 mikrogram/dos nässpray, suspension

    The George Institute

    Allergic rhinitis due to dog allergy

    approved small molecule active

    1 trial

  3. Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar sus

    Pfizer Australia Pty Ltd

    VACCINE-TYPE RADIOLOGICALLY-CONFIRMED COMMUNITY-ACQUIRED PNEUMONIA

    approved small molecule active

    1 trial

  4. Betadine bucal 100 mg/ml solución bucal, Agua oxigenada Foret 3 % solución cutánea y concentrado para solución bucal, Agua para preparaciones inyectables Meinsol, disolvente para uso parenteral

    The George Institute

    Respiratory diseases

    approved small molecule active

    1 trial

  5. CHORIOGONADOTROPIN ALFA , ESTRADIOL , PROGESTERONE

    The George Institute

    Infertility

    approved small molecule active

    1 trial

  6. COLECALCIFEROL , The Placebo product consists only of pure Ph. Eur. refined olive and it differs from Test product for the absence of active substance only: therefore, there are no reasons to suspect that the placebo product will undergo changes in its physical characteristics or degradation., Placebo

    Fondazione Telethon ETS

    obese elderly people with vitamin D deficiency

    approved small molecule active

    1 trial

  7. ENZALUTAMIDE, DOCETAXEL, ABIRATERONE

    Fondazione Telethon ETS

    metastatic castration resistant prostate cancer without mutations of BRCA1/2 genes or unknown

    approved small molecule active

    1 trial

  8. ESTRIOL , ESTRADIOL HEMIHYDRATE, PROMESTRIENE, PROGESTERONE, ESTRADIOL VALERATE

    The George Institute

    Cervical cancer

    approved small molecule active

    1 trial

  9. ETHINYL ESTRADIOL AND LEVOGESTREL

    United Therapeutics Europe Ltd

    HIV/AIDS

    approved small molecule completed

    1 trial

  10. Fill out Questionnaire

    Rhythm Pharmaceuticals Netherlands B.V.

    Bradycardia

    approved other completed

    1 trial

  11. Ivabradine + Usual Care

    The University of Hong Kong

    Atrial Fibrillation (Permanent)

    approved small molecule active

    1 trial

  12. Lesinurad

    IRONWOOD PHARMACEUTICALS INC

    Gout

    approved small molecule terminated

    1 trial

  13. Metformin Actavis 500 mg filmdragerad tablett

    The George Institute

    Polycystic ovary syndrome

    approved small molecule active

    1 trial

  14. Microcrystalline cellulose, GABAPENTINE BIOGARAN 300 mg, gélule

    The George Institute

    lumbosacral radiculalgia

    approved small molecule active

    1 trial

  15. Placebo to AIN457 150 mg/1 mL Solution for injection in pre-filled syringe, SECUKINUMAB

    Novartis Pharmaceuticals

    non-radiographic axial spondyloarthritis

    approved small molecule active

    1 trial

  16. Placebo used in this trial is a foodgrade, redried potato starch. It is a white powder with bland taste and free from objectionable odours. Insoluble in water with a temperature below 50 °C and most organic solvents, solution is slightly hazy. The product is intended for use in food., POTATO STARCH, SODIUM CHLORIDE, AMILORIDE

    Disc Medicine

    Autosomal Dominant Polycystic Kidney Disease

    approved small molecule active

    1 trial

  17. Radio-Flu 0,1 - 4 GBq/ml oplossing voor injectie, MIBG (I123) 74 MBq/mL oplossing voor injectie Jobenguaan (123I)

    Disc Medicine

    Transthyretin amyloid cardiomyopathy

    approved small molecule active

    1 trial

  18. Ropivacaine

    The First People's Hospital of Lianyungang

    Radius Fractures

    approved small molecule completed

    1 trial

  19. SINECATECHINS

    The George Institute

    Anal high-grade squamous intraepithelial lesions (HSIL).

    approved small molecule active

    1 trial

  20. Scheduled Gradual Reduction + Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Addiction

    approved other terminated

    1 trial

  21. Sodium Chloride 0.9%, Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    Disc Medicine

    Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)

    approved small molecule active

    1 trial

  22. Sodium Chloride Fresenius Kabi Italia 0.9 % Solution for infusion , DENOSUMAB, Sodium Fluoride (18F) Life Radiopharma 0,1 - 4 GBq/ml solution injectable

    Disc Medicine

    Fibrous dysplasia/McCune-Albright syndrome

    approved small molecule active

    1 trial

  23. SomaKit TOC 40 micrograms kit for radiopharmaceutical preparation

    Ningbo Cancer Hospital

    Gastroenteropancreatic neuroendocrine tumors

    approved small molecule active

    1 trial

  24. Stereotactic Radiation Therapy

    GT Biopharma

    Glioblastoma

    approved other terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources